Pancreatic Cancer Research

ResearcherShanghai UniversityActive in the last 2 years

Hui Cai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6182-966X; OpenAlex author ID A5091565157. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

  1. Association between D-dimer levels and clinicopathological characteristics of pancreatic cancer and its role in prognosis: A systematic review and meta-analysi… Last author DOI 10.1016/j.asjsur.2024.02.043↗
  2. Targeted delivery of a PROTAC induced PDEδ degrader by a biomimetic drug delivery system for enhanced cytotoxicity against pancreatic cancer cells. Co-author PMID 35411249↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jie Wang · 1 shared paper, 2024 · strength 0.23
  2. Bin Wu · 1 shared paper, 2024 · strength 0.23
  3. Ruyu Fan · 1 shared paper, 2022 · strength 0.14
  4. Shipeng He · 1 shared paper, 2022 · strength 0.14
  5. Huafei Li · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.